A Dose Escalation Trial of Biweekly Docetaxel and Gemcitabine with Filgrastim or Pegfilgrastim for the Treatment of Patients with Advanced Solid Tumors

Publisher： Karger

E-ISSN： 1421-9794|56|2|135-141

ISSN： 0009-3157

Source： Chemotherapy, Vol.56, Iss.2, 2010-04, pp. : 135-141

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dose Escalation Study of Epirubicin and Docetaxel in Patients with Advanced or Recurrent Breast Cancer

By  

Chemotherapy, Vol. 54, Iss. 5, 2008-08 ,pp. : 379-385

Karger

Access to resources Recommend Favorite

A Randomized Phase II Trial of Gemcitabine plus Carboplatin: Biweekly versus Standard Schedules in Patients with Advanced Non-Small Cell Lung Cancer

By  

Chemotherapy, Vol. 59, Iss. 5, 2014-05 ,pp. : 346-353

Karger

Access to resources Recommend Favorite

Phase I Trial Using Weekly Administration of Gemcitabine and Docetaxel in Patients with Advanced Pancreatic Carcinoma

By  

Chemotherapy, Vol. 50, Iss. 6, 2004-12 ,pp. : 289-296

Karger

Access to resources Recommend Favorite

Phase I Trial of Intravenous Cisplatin-Topotecan Chemotherapy for Three Consecutive Days in Patients with Advanced Solid Tumors: Parallel Topotecan Escalation in Two Fixed Platinum Dosing Schemes

By  

Chemotherapy, Vol. 51, Iss. 2-3, 2005-06 ,pp. : 154-161

Karger

Access to resources Recommend Favorite

Phase II Trial of Biweekly Chemotherapy with Docetaxel and Cisplatin in High-Risk Patients with Unresectable Non-Small Cell Lung Cancer

By  

Chemotherapy, Vol. 59, Iss. 3, 2013-10 ,pp. : 159-166

Karger

Access to resources Recommend Favorite